Karo Healthcare names Sue Egstrand as new CEO
Karo Healthcare has appointed industry veteran Sue Egstrand as its new Chief Executive Officer, effective January 1, 2027. She will spearhead the company’s expansion strategy within the European consumer health market.
European consumer healthcare firm Karo Healthcare has appointed Sue Egstrand as its new Chief Executive Officer. Egstrand is scheduled to assume the position on January 1, 2027, taking over the helm as the company seeks to scale its operations and influence across the continent.
Egstrand joins Karo with a background in international healthcare management, having previously held senior leadership roles at Reckitt, including Senior Vice President for Europe Health. Her professional history also includes management tenures at Pfizer and GSK, where she gained experience in commercial development and regional strategy across diverse markets.
The leadership transition follows Karo’s stated objective to move into the top five of the European consumer healthcare sector. Egstrand’s appointment is expected to solidify the company's organizational structure as it pursues its long-term growth and market-share targets.